• 781 Citations
  • 14 h-Index
20042019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where J. Dobos is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 781 Citations
  • 14 h-Index
  • 26 Article
  • 2 Review article
  • 1 Comment/debate
  • 1 Letter

Discovery and development of extreme selective inhibitors of the ITD and D835Y mutant FLT3 kinases

Baska, F., Sipos, A., Őrfi, Z., Nemes, Z., Dobos, J., Szántai-Kis, C., Szabó, E., Szénási, G., Dézsi, L., Hamar, P., Cserepes, M. T., Tóvári, J., Garamvölgyi, R., Krekó, M. & Őrfi, L., Dec 15 2019, In : European Journal of Medicinal Chemistry. 184, 111710.

Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    Targeted drug combination therapy design based on driver genes

    Zsákai, L., Sipos, A., Dobos, J., Eros, D., Szántai-Kis, C., Bánhegyi, P., Pató, J., Orfi, L., Matula, Z., Mikala, G., Kéri, G., Peták, I. & Vályi-Nagy, I., Jan 1 2019, In : Oncotarget. 10, 51, p. 5255-5266 12 p.

    Research output: Contribution to journalArticle

  • Inhibition of epidermal growth factor receptor improves antitumor efficacy of vemurafenib in BRAF-mutant human melanoma in preclinical model

    Kenessey, I., Kramer, Z., István, L., Cserepes, M. T., Garay, T., Hegedűs, B., Dobos, J., Tímár, J. & Tóvári, J., Dec 1 2018, In : Melanoma Research. 28, 6, p. 536-546 11 p.

    Research output: Contribution to journalArticle

  • 4 Citations (Scopus)